Seroprevalence and Risk Factors for Hepatitis B Virus Infection in Adolescent Blood Donors Within Selected Counties of Western Kenya

Abstract

Hepatitis B virus is a widespread public health menace approximated to have infected 257 million people chronically by 2015. Data on the prevalence of HBV is important in formulating public health policies on HBV control like safe blood transfusion. Adolescents aged 15 to 24 years, known to engage in risky activities associated with HBV spread, constitute major blood donors in Kenya. Notwithstanding current blood donation safety measures, HBV still remain hazardous transfusion-transmissible infections in donated blood. This study therefore was to determine the prevalence of HBsAg and related risk factors among this donor group. A cross-sectional study was conducted from April 2019 to August 2019 in Siaya, Kisumu, and Homa Bay counties. One thousand (1000) voluntary blood donors 18 to 25 years old were recruited. A predonation questionnaire was used to record their sociodemographic features and prior risk exposures. Blood samples were initially tested for HBsAg using Murex HBsAg Version 3 (DiaSorin, UK) and positives confirmed using ARCHITECT HBsAg Qualitative Confirmatory assay (Abbott Ireland) as per the manufacturer’s instructions. A result was considered positive if the first and confirmatory tests were all reactive. Generally, the prevalence of HBV was 3.4%, with no significant association between various sociodemographic variables and HBsAg positivity. Nevertheless, scarification and risky sexual behavior were significantly linked to HBV infections (odds ratio ðORÞ = 8:533, 95%confidence interval ðCIÞ = 3:128‐23:275, p value of 0.001 and OR = 5:471, 95%CI = 1:925‐15:547, p value of 0.002, respectively). This study revealed a prevalence of 3.4% HBsAg among adolescent blood donors, with perilous sexual behaviors being the most significant risk factor, evidence that sexual contact still plays a major role in transmission of HBV among this donor group despite blood transfusion safety measures put in place. These study findings should therefore be put into consideration while framing health policies to mitigate effects of HBV infection on safe blood transfusion.